X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1154) 1154
Newspaper Article (297) 297
Publication (78) 78
Patent (38) 38
Conference Proceeding (16) 16
Dissertation (12) 12
Book / eBook (10) 10
Book Review (10) 10
Book Chapter (6) 6
Magazine Article (4) 4
Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (552) 552
male (358) 358
index medicus (351) 351
female (329) 329
cardiac & cardiovascular systems (288) 288
middle aged (253) 253
heart failure (230) 230
aged (224) 224
cardiovascular (169) 169
mortality (160) 160
adult (130) 130
heart failure - drug therapy (126) 126
treatment outcome (118) 118
medicine, general & internal (117) 117
hypertension (113) 113
animals (112) 112
risk factors (96) 96
care and treatment (88) 88
double-blind method (88) 88
drug therapy (86) 86
blood pressure (81) 81
heart failure - physiopathology (80) 80
pharmacology & pharmacy (80) 80
peripheral vascular disease (78) 78
chronic disease (75) 75
myocardial-infarction (74) 74
prospective studies (72) 72
abridged index medicus (71) 71
hypertension - drug therapy (63) 63
aged, 80 and over (62) 62
heart failure - mortality (62) 62
rats (62) 62
research (62) 62
follow-up studies (60) 60
risk (60) 60
cardiac patients (59) 59
cardiovascular disease (58) 58
clinical trials (57) 57
analysis (55) 55
blood pressure - drug effects (55) 55
adrenergic beta-antagonists - therapeutic use (54) 54
disease (54) 54
trial (54) 54
myocardial infarction (52) 52
survival (49) 49
time factors (49) 49
heart failure - diagnosis (48) 48
diabetes (46) 46
prognosis (46) 46
therapy (46) 46
blood-pressure (45) 45
heart failure - therapy (45) 45
antihypertensive agents - therapeutic use (44) 44
cardiovascular diseases (43) 43
double-blind (43) 43
angiotensin-converting enzyme inhibitors - therapeutic use (42) 42
australia (42) 42
hypertension - physiopathology (41) 41
management (41) 41
drug therapy, combination (40) 40
heart attacks (40) 40
fibrosis (38) 38
morbidity (38) 38
hospitalization (37) 37
outcomes (37) 37
carvedilol (36) 36
dose-response relationship, drug (36) 36
heart-failure (36) 36
left-ventricular dysfunction (36) 36
rats, sprague-dawley (36) 36
diagnosis (35) 35
kidney - innervation (35) 35
patient outcomes (35) 35
heart (34) 34
prevention (34) 34
echocardiography (33) 33
health aspects (33) 33
studies (33) 33
association (32) 32
cardiology (32) 32
internal medicine (32) 32
randomized-trial (32) 32
acute myocardial-infarction (31) 31
blood pressure - physiology (31) 31
medicine & public health (31) 31
metaanalysis (31) 31
randomized controlled trials as topic (31) 31
electrocardiography (30) 30
guidelines (30) 30
hiv infections - drug therapy (30) 30
severity of illness index (30) 30
angiotensin (29) 29
clinical medicine (29) 29
incidence (29) 29
medical research (29) 29
resistant hypertension (29) 29
spironolactone - analogs & derivatives (29) 29
aldosterone (28) 28
physiology (28) 28
spironolactone (28) 28
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Stacks (1) 1
Online Resources - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1508) 1508
German (13) 13
Bulgarian (7) 7
French (6) 6
Portuguese (5) 5
Spanish (4) 4
Dutch (2) 2
Czech (1) 1
Italian (1) 1
Macedonian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2016, Volume 374, Issue 21, pp. 2021 - 2031
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2016, Volume 374, Issue 21, pp. 2009 - 2020
Journal Article